Cargando…
Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment
IMPORTANCE: Age-related macular degeneration (AMD) remains the leading cause of blindness in developed countries, and affects more than 150 million worldwide. Despite effective anti-angiogenic therapies for the less prevalent neovascular form of AMD, treatments are lacking for the more prevalent dry...
Autores principales: | Vavvas, Demetrios G., Daniels, Anthony B., Kapsala, Zoi G., Goldfarb, Jeremy W., Ganotakis, Emmanuel, Loewenstein, John I., Young, Lucy H., Gragoudas, Evangelos S., Eliott, Dean, Kim, Ivana K., Tsilimbaris, Miltiadis K., Miller, Joan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816836/ https://www.ncbi.nlm.nih.gov/pubmed/27077128 http://dx.doi.org/10.1016/j.ebiom.2016.01.033 |
Ejemplares similares
-
Assessment of a Novel Semi-Automated Algorithm for the Quantification of the Parafoveal Capillary Network
por: Kapsala, Zoi, et al.
Publicado: (2023) -
Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021) -
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023) -
Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication
por: Vavvas, Demetrios G., et al.
Publicado: (2020) -
Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD
por: Tsilimbaris, Miltiadis K., et al.
Publicado: (2016)